Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Rolls-Royce Holdings | 7.48% | $68.82M | £102.13B | 124.42% | 71 Outperform | |
| Babcock International | 5.69% | $52.37M | £7.15B | 166.73% | 67 Neutral | |
| Teva Pharmaceutical | 3.40% | $31.25M | $37.48B | 92.22% | 63 Neutral | |
| Siemens Energy | 3.24% | $29.80M | $146.22B | 187.18% | 72 Outperform | |
| Prosus | 3.15% | $28.95M | €105.84B | 49.75% | 77 Outperform | |
| Societe Generale | 2.87% | $26.39M | €48.90B | 136.71% | 72 Outperform | |
| Companhia De Saneamento | 2.83% | $26.06M | $18.89B | 70.93% | 71 Outperform | |
| Tokyo Electron | 2.70% | $24.88M | ¥18.93T | 69.11% | 73 Outperform | |
| Novo Nordisk | 2.49% | $22.93M | $260.74B | -29.63% | 73 Outperform | |
| Brookfield Corporation | 2.45% | $22.55M | $112.85B | 11.64% | 65 Neutral |